Here, we demonstrate that SEMA3C, an autocrine prostate cancer growth factor, can induce the expression of key steroidogenic enzymes while simultaneously suppressing the expression of androgen-inactivating enzymes leading to increased synthesis of androgens such as testosterone and DHT from adrenal hormones such as DHEA or de novo from cholesterol. This evidence concerns the gene SEMA3C and prostate carcinoma.